SS-31

SS-31 peptide (also known as Elamipretide or MTP-131) is a mitochondria-targeting peptide designed to support cellular energy production and reduce oxidative stress. By binding to cardiolipin within the inner mitochondrial membrane, SS-31 helps improve mitochondrial function and promote efficient ATP generation. As a result, researchers continue to investigate its potential applications in healthy aging, cardiovascular health, muscle performance, and neuroprotection.

How SS-31 Peptide Works

Unlike many peptides, specifically targets mitochondria, the energy-producing structures inside cells. It interacts with cardiolipin to stabilize mitochondrial membranes and reduce the production of harmful reactive oxygen species. Consequently, this mechanism may help support cellular function and protect tissues from oxidative damage.

Potential Benefits

Researchers are studying SS-31 peptide for several possible benefits, including:

• Supporting mitochondrial energy production
• Reducing oxidative stress
• Promoting muscle endurance and recovery
• Supporting cardiovascular health
• Enhancing cognitive and neurological function
• Protecting kidney and retinal tissues
• Supporting healthy aging processes

Research and Clinical Development

Scientific studies have shown that it may improve mitochondrial efficiency and reduce cellular damage in various experimental models. In addition, clinical research has explored its use in mitochondrial disorders and age-related conditions. Elamipretide received FDA approval in 2025 for the treatment of Barth syndrome, highlighting its therapeutic potential. However, many applications remain under investigation.

Why Choose SS-31 Peptide?

it has attracted significant interest because of its unique ability to target mitochondrial dysfunction directly. Therefore, it has become one of the most researched peptides in the fields of longevity, cellular health, and metabolic support. Ongoing studies continue to evaluate its safety and effectiveness for broader therapeutic uses.